Cite
CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.
MLA
Magg, Thomas, et al. “CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.” Inflammatory Bowel Diseases, vol. 25, no. 11, Oct. 2019, pp. 1788–95. EBSCOhost, https://doi.org/10.1093/ibd/izz103.
APA
Magg, T., Shcherbina, A., Arslan, D., Desai, M. M., Wall, S., Mitsialis, V., Conca, R., Unal, E., Karacabey, N., Mukhina, A., Rodina, Y., Taur, P. D., Illig, D., Marquardt, B., Hollizeck, S., Jeske, T., Gothe, F., Schober, T., Rohlfs, M., … Kotlarz, D. (2019). CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 25(11), 1788–1795. https://doi.org/10.1093/ibd/izz103
Chicago
Magg, Thomas, Anna Shcherbina, Duran Arslan, Mukesh M Desai, Sarah Wall, Vanessa Mitsialis, Raffaele Conca, et al. 2019. “CARMIL2 Deficiency Presenting as Very Early Onset Inflammatory Bowel Disease.” Inflammatory Bowel Diseases 25 (11): 1788–95. doi:10.1093/ibd/izz103.